查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1927373

經經皮冠狀動脈旋磨術市場按產品類型、病變類型、最終用戶和適應症分類－2026-2032年全球預測

Percutaneous Transluminal Coronary Rotational Atherectomy Market by Product Type, Lesion Type, End User, Indication - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年經皮冠狀動脈旋磨術市場價值為 9,086 萬美元，預計到 2026 年將成長至 1.0456 億美元，年複合成長率為 12.71%，到 2032 年將達到 2.1007 億美元。

關鍵市場統計數據
基準年 2025 9086萬美元
預計年份：2026年 1.0456億美元
預測年份 2032 2.1007億美元
複合年成長率 (%) 12.71%

旋轉動脈粥狀硬化斑塊切除術簡介：全面介紹現代介入性心臟病學中的臨床原理、器械發展歷程和手術整合。

經皮冠狀動脈旋磨術（PTC）是一種專門用於改善冠狀動脈鈣化斑塊、便於器械輸送並提高手術效果的血管內技術。該技術結合了機械減容、高速旋轉磨鑽以及輔助介入策略，旨在最佳化支架植入，並恢復傳統球囊血管成形術無效病變的冠狀動脈灌注。過去十年，技術的改進、磨鑽工程的進步以及輔助引導和沖洗技術的提升，共同提高了PTC治療複雜鈣化病變的臨床可靠性。

技術、影像和臨床實踐的發展趨勢正在重新定義複雜冠狀動脈介入治療中旋切動脈粥狀硬化斑塊切除術的選擇和實施方式。

冠狀動脈旋動脈粥狀硬化斑塊切除術領域正經歷著變革性的轉變，這主要得益於技術創新、手術技巧的精進以及更廣泛的臨床應用。微型化和材料科學的進步催生了新一代的磨頭和系統元件，這些組件在保持有效去除鈣化病變的同時，顯著提高了在複雜解剖結構中的操作靈活性。同時，血管內超音波和光學同調斷層掃描（OCT）等影像技術的進步，使得病灶特徵的精確表徵成為可能，從而指導磨頭的選擇和手術策略的發展。

美國關稅變化對醫療設備相關人員的營運影響：推動供應鏈重組、合約重新談判和策略性在地化

美國近期關稅調整為心血管器械製造商、經銷商和採購機構帶來了新的營運考量。進口關稅和分類通訊協定的變化影響了通常在多個司法管轄區生產的零件的到岸成本，促使採購團隊重新評估籌資策略和庫存政策。因此，一些供應商已開始進行區域化生產並調整物流流程，以降低關稅風險，並為醫院系統和專科診所維持價格競爭力。

分段分析揭示了產品組件、病變形態、臨床適應症和治療環境如何相互作用，從而影響器械選擇和手術結果。

基於產品細分的洞察揭示了不同系統平台、耗材組件和特定尺寸鑽頭產品線中細微的性能促進因素。諸如沖洗盒、導管導引線和旋轉適配器等配件在手術安全性和效率方面發揮關鍵作用，而系統級特性則決定了與各種鑽頭輪廓的兼容性以及操作者的舒適度。在動脈粥狀硬化斑塊切除術鑽頭類別中，小型、中型和大型鑽頭的不同設計特性會影響病變矯正策略和與下游設備的兼容性，進而影響臨床選擇。

影響美洲、歐洲、中東和非洲以及亞太地區臨床應用、供應鏈策略和培訓重點的區域趨勢

區域趨勢對旋切動脈粥狀硬化斑塊切除術技術的應用、監管合規性和臨床醫生培訓有顯著影響。在美洲，成熟的介入治療網路和先進的手術基礎設施為先進動脈粥狀硬化斑塊切除術系統的應用提供了支持，而報銷機制和大型醫院集團的採購協議則影響著採購週期和資本支出。相較之下，在歐洲、中東和非洲地區，不同的法規環境和先進影像技術的普及程度差異影響著旋切術的普及率，凸顯了模組化系統設計的重要性，這種設計能夠適應不同的臨床實踐環境。

企業層面的競爭和策略趨勢強調產品差異化、夥伴關係、證據產生以及對整個設備組合的全生命週期支持。

醫療器材產業的競爭格局由漸進式產品創新、策略聯盟和以手術相容性和臨床操作便利性為優先的商業化措施所驅動。製造商在諸如磨頭材料科學、輸送導管的柔軟性以及與成像平台整合的介面等方面展開競爭，這些介面可在病灶形成過程中提供即時回饋。隨著臨床團隊尋求能夠縮短手術時間、提高安全裕度並融入現有導管室工作流程的器械，這些特性對於產品差異化的重要性日益凸顯。

為確保永續應用，對醫療器材製造商和醫療系統提出具體建議：優先考慮創新、臨床醫生培訓、合約柔軟性和供應鏈韌性。

產業領導者應優先考慮提升設備與先進成像技術的兼容性、簡化操作人員的工作流程，並確保供應鏈的韌性，以減少貿易中斷的影響。投資於臨床醫生培訓，包括實踐模擬和遠端監控，將加速安全應用，並建立卓越中心，作為更廣泛推廣的參考範例。從商業性角度來看，建立靈活的合約模式和基於價值的提案，兼顧手術總成本和臨床療效，可以增強您在醫院採購團隊中的地位。

為了確保分析的嚴謹性，我們採用了穩健的混合方法研究通訊協定，該方案結合了與臨床醫生的直接接觸、二次臨床文獻審查和數據三角驗證。

本研究途徑結合了與介入性心臟病專家、導管檢查室經理和採購人員的結構化一手調查，以及對臨床文獻、醫療設備監管申報文件和操作指南的二手分析。一手資料包括深度訪談和結構化調查問卷，旨在深入了解臨床決策促進因素、裝置偏好和操作限制。二手資訊則著重於同儕審查的證據和共識聲明，這些證據和聲明提供了最佳實踐，以支持臨床路徑、技術規範和監管趨勢。

對決定冠狀動脈旋磨術目前及近期發展方向的臨床、技術和商業性動態進行綜合分析

總之，經經皮冠狀動脈旋磨術在設備不斷改進、影像融合技術增強以及臨床醫生經驗日益豐富的支持下，在複雜鈣化冠狀動脈疾病的治療中發揮越來越重要的作用。產品創新、手術標準化和採購趨勢的演變正在重塑醫療機構在各種臨床環境中選擇和實施斑塊消融策略的方式。那些能夠將產品開發與臨床醫生需求相結合、投資於可擴展的培訓並積極應對供應鏈脆弱性的相關人員，將更有利於提供臨床價值和保障業務連續性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 經經皮冠狀動脈旋磨術市場（依產品類型分類）

  • 配件
    • 閃光盒
    • 導管導引線
    • 旋轉適配器
  • 動脈粥狀硬化斑塊切除術棒
    • 大酒吧
    • 中酒吧
    • 小酒吧
  • 動脈粥狀硬化斑塊切除術系統

第9章 經經皮冠狀動脈旋磨術市場（依病變類型分類）

  • 輕度鈣化
  • 中度鈣化
  • 非鈣化性病變
  • 嚴重鈣化

第10章 經經皮冠狀動脈旋磨術市場（依最終用戶分類）

  • 門診手術中心
  • 心臟診所
  • 醫院

第11章 經經皮冠狀動脈旋磨術市場（依適應症分類）

  • 非ST段上升型心肌梗塞（NSTEMI）
  • 穩定性心絞痛
  • ST段上升型心肌梗塞
  • 不穩定型心絞痛

第12章 經經皮冠狀動脈旋磨術市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 經經皮冠狀動脈旋磨術市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國經經皮冠狀動脈旋磨術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國經皮冠狀動脈旋磨術市場

第16章 中國經皮冠狀動脈旋磨術市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Avinger, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Cardiovascular Systems, Inc.
  • Cook Medical LLC
  • INVAMED
  • Koninklijke Philips NV
  • Medtronic PLC
  • NEScientific, Inc
  • NIPRO CORPORATION
  • RA Medical Systems, Inc.
  • Rotarex, SA by Becton, Dickinson and Company
  • Terumo Corporation
Product Code: MRR-4F7A6D4FF381

The Percutaneous Transluminal Coronary Rotational Atherectomy Market was valued at USD 90.86 million in 2025 and is projected to grow to USD 104.56 million in 2026, with a CAGR of 12.71%, reaching USD 210.07 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 90.86 million
Estimated Year [2026] USD 104.56 million
Forecast Year [2032] USD 210.07 million
CAGR (%) 12.71%

Comprehensive introduction to rotational atherectomy that frames clinical rationale, device evolution, and procedural integration across contemporary interventional cardiology

Percutaneous transluminal coronary rotational atherectomy represents a specialized endovascular technique focused on modifying calcified coronary plaques to facilitate device delivery and improve procedural outcomes. The technique combines mechanical debulking using high-speed rotational burrs with adjunctive interventional strategies to optimize stent deployment and restore coronary perfusion in lesions that are resistant to conventional balloon angioplasty. Over the past decade, procedural refinements, engineering advances in burr geometry, and improvements in adjunctive guide and flush technologies have collectively raised clinical confidence in treating complex calcified disease.

Clinicians increasingly view this therapy as a targeted option for patients with severe calcification or lesion characteristics that limit crossing and expansion of standard devices. As a result, device design has evolved to emphasize deliverability, compatibility with advanced imaging, and control of particulate debris. Consequently, hospitals and specialty cardiac centers have introduced protocolized pathways to identify appropriate candidates and to integrate rotational atherectomy within hybrid treatment algorithms. These developments have reshaped procedural planning, operator training, and supply chain considerations for high-acuity cardiac programs.

Transformational currents in technology, imaging, and clinical practice that are redefining how rotational atherectomy is selected and performed in complex coronary interventions

The landscape of coronary rotational atherectomy is undergoing transformative shifts driven by technological innovation, refined procedural techniques, and broader clinical adoption patterns. Miniaturization and enhanced materials science have produced a new generation of burrs and system components that improve navigability through tortuous anatomy while maintaining effective calcific modification. Concurrently, imaging enhancements such as intravascular ultrasound and optical coherence tomography have enabled precise lesion characterization, which in turn informs burr selection and procedural strategy.

Beyond hardware, operator competency models have expanded with structured proctoring and simulation-based training that accelerate skill acquisition while reducing complication rates. Reimbursement and institutional protocols have adapted to incorporate multidisciplinary decision-making, where interventional cardiologists, imaging specialists, and vascular teams jointly determine the appropriateness of rotational atherectomy for complex lesions. As a result, the modality is transitioning from a niche rescue technique to a considered option within the armamentarium for calcified coronary disease, supported by iterative device improvements and evidence-informed practice patterns.

Operational repercussions of revised United States tariffs that are prompting supply chain realignment, contract renegotiation, and strategic localization for device stakeholders

Recent tariff adjustments in the United States have introduced new operational considerations for manufacturers, distributors, and purchasing organizations involved with cardiovascular devices. Changes in import duties and classification protocols have affected landed costs for components that are often manufactured across multiple jurisdictions, prompting procurement teams to reassess sourcing strategies and inventory policies. Consequently, some suppliers have initiated regional consolidation of manufacturing and adjusted logistics flows to mitigate tariff exposure and to preserve competitive pricing for hospital systems and specialty clinics.

In response, health systems and device providers have revisited vendor contracts to incorporate clauses addressing tariff volatility and to establish contingency plans for supply continuity. Moreover, the evolving duty landscape has influenced decisions regarding local assembly, compliance documentation, and product labeling to optimize customs treatment. For clinical programs, these shifts underscore the importance of visibility into supply chains and proactive collaboration with suppliers to maintain equipment availability, protect procedure scheduling, and sustain patient care pathways amid changing trade conditions.

Segment-driven analysis revealing how product components, lesion morphology, clinical indications, and care settings converge to influence device selection and procedural outcomes

Insights derived from product-based segmentation reveal nuanced performance drivers across system platforms, consumable components, and size-specific burr offerings. Accessories such as flush cassettes, guide wires, and rotational adapters play a pivotal role in procedural safety and efficiency, while system-level attributes determine compatibility with diverse burr profiles and operator ergonomics. Within the atherectomy burr category, differentiated design characteristics across small, medium, and large burrs influence lesion modification strategies and downstream device compatibility, thereby shaping choice at the point of care.

When the lesion-type segmentation is applied, clinical decision-making aligns with lesion morphology, where non-calcified and mildly calcified lesions may be managed conservatively or with adjunctive balloon strategies, while moderate to severe calcifications frequently necessitate ablative approaches to ensure luminal gain and stent expansion. End-user segmentation highlights distinct procurement and usage patterns: ambulatory surgical centers emphasize throughput and device portability, cardiac specialty clinics prioritize procedure-specific disposables and simplified inventory, and hospitals concentrate on comprehensive device ecosystems that support complex cases and backup capabilities. In parallel, indication-based segmentation across NSTEMI, stable angina, STEMI, and unstable angina underscores the need for rapid assessment, triage, and tailored device selection aligned to acute versus elective procedural contexts.

Regional dynamics shaping clinical adoption, supply chain strategies, and training priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific territories

Regional dynamics exert a pronounced influence on technology adoption, regulatory navigation, and clinician training for rotational atherectomy. In the Americas, established interventional networks and advanced procedural infrastructure support the integration of sophisticated atherectomy systems, while reimbursement frameworks and large hospital group purchasing arrangements shape procurement cycles and capital investments. Conversely, Europe, the Middle East & Africa present heterogeneous regulatory environments and variable access to advanced imaging that affect uptake rates and the emphasis on modular system designs that accommodate diverse practice settings.

Asia-Pacific markets demonstrate accelerating clinical volume and an expanding base of trained operators, driven in part by demographic shifts and growing prevalence of complex coronary disease. Local manufacturing initiatives and regional partnerships in this geography have shortened supply chains and introduced price-competitive alternatives, influencing device portfolios available to cardiac programs. Across all regions, cross-border collaboration on training, combined with remote proctoring and digital education, is contributing to a more even distribution of procedural expertise and an expanding cohort of clinicians proficient in plaque modification techniques.

Competitive and strategic company-level trends emphasizing product differentiation, partnerships, evidence generation, and lifecycle support across device portfolios

Competitive dynamics in the device landscape are driven by incremental product innovation, strategic partnerships, and targeted commercialization efforts that prioritize procedural compatibility and clinician usability. Manufacturers are competing on aspects such as burr material science, delivery catheter flexibility, and interfaces that integrate with imaging platforms to provide real-time feedback during lesion preparation. These capabilities are increasingly central to product differentiation as clinical teams seek devices that reduce procedural time, enhance safety margins, and integrate into existing cath lab workflows.

In addition, strategic alliances between device developers, imaging providers, and distribution partners enable bundled offerings that simplify procurement and training for hospital systems. Industry participants are investing in evidence generation and in educational initiatives to demonstrate technique reproducibility and to expand the pool of operators competent in rotational atherectomy. As competitive intensity grows, there is a parallel focus on lifecycle management, aftermarket support for single-use components, and services that reduce total procedural complexity for high-volume cardiac centers.

Actionable recommendations for device makers and health systems to prioritize innovation, clinician training, contractual flexibility, and supply chain resilience for sustained adoption

Industry leaders should prioritize initiatives that enhance device compatibility with advanced imaging, streamline operator workflows, and secure resilient supply chains that mitigate trade-related disruptions. Investment in clinician education, including hands-on simulation and remote proctoring, will accelerate safe adoption and create centers of excellence that can serve as reference sites for broader rollout. From a commercial standpoint, building flexible contracting models and value-based propositions that address total procedural costs and clinical outcomes will strengthen positioning with hospital procurement teams.

Operationally, executives should evaluate geographic manufacturing footprints and logistics partners to reduce exposure to tariff volatility while preserving the ability to scale production. Product teams ought to continue refining burr geometry and accessory ergonomics to address a spectrum of lesion morphologies and care settings, with particular attention to disposables that impact procedure throughput. Finally, fostering collaborative research with clinical leaders to publish real-world evidence will support credibility and inform guideline-consistent adoption pathways across acute and elective care environments.

Robust mixed-methods research protocol combining primary clinician engagement, secondary clinical literature review, and data triangulation to ensure analytical rigor

The research approach combined structured primary engagement with interventional cardiologists, cath lab managers, and procurement leaders with targeted secondary analysis of clinical literature, device regulatory filings, and procedural guidelines. Primary inputs included in-depth interviews and structured questionnaires designed to elicit qualitative insights on clinical decision drivers, device preferences, and operational constraints. Secondary sources were reviewed to corroborate clinical pathways, technology specifications, and regulatory trends, with attention to peer-reviewed evidence and consensus statements that inform best practices.

Data integrity was ensured through triangulation across multiple information streams, reconciliation of interview findings with published procedural literature, and iterative validation with domain experts. Analytical steps included thematic coding of qualitative responses, cross-segmentation synthesis to surface actionable insights, and sensitivity checks to ensure that conclusions were robust to differing clinical perspectives. Ethical safeguards and confidentiality protocols governed primary data collection, ensuring candid input from stakeholders and protecting commercially sensitive information.

Concluding synthesis of clinical, technological, and commercial dynamics that define the present and near-term trajectory of coronary rotational atherectomy

In summary, percutaneous transluminal coronary rotational atherectomy occupies an increasingly important role in the management of complex calcified coronary disease, supported by iterative device refinements, enhanced imaging integration, and expanding clinician expertise. The confluence of product innovation, procedural standardization, and evolving procurement dynamics is reshaping how providers select and implement plaque modification strategies across diverse care settings. Stakeholders who align product development with clinician needs, invest in scalable training, and proactively address supply chain vulnerabilities will be best positioned to deliver clinical value and operational continuity.

As the clinical community continues to refine indications and optimize technique, ongoing collaboration between device makers, clinical leaders, and health system purchasers will be essential. This collaborative approach will facilitate the translation of technical advances into measurable improvements in procedural success, patient safety, and resource efficiency, thereby supporting the broader adoption of lesion-specific strategies for challenging coronary anatomies.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Flush Cassettes
    • 8.1.2. Guide Wires
    • 8.1.3. Rotational Adapters
  • 8.2. Atherectomy Burrs
    • 8.2.1. Large Burrs
    • 8.2.2. Medium Burrs
    • 8.2.3. Small Burrs
  • 8.3. Atherectomy Systems

9. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Lesion Type

  • 9.1. Mild Calcification
  • 9.2. Moderate Calcification
  • 9.3. Non Calcified Lesions
  • 9.4. Severe Calcification

10. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Cardiac Specialty Clinics
  • 10.3. Hospitals

11. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Indication

  • 11.1. Nstemi
  • 11.2. Stable Angina
  • 11.3. Stemi
  • 11.4. Unstable Angina

12. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Percutaneous Transluminal Coronary Rotational Atherectomy Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Percutaneous Transluminal Coronary Rotational Atherectomy Market

16. China Percutaneous Transluminal Coronary Rotational Atherectomy Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Avinger, Inc.
  • 17.7. B. Braun SE
  • 17.8. Boston Scientific Corporation
  • 17.9. Cardiovascular Systems, Inc.
  • 17.10. Cook Medical LLC
  • 17.11. INVAMED
  • 17.12. Koninklijke Philips N.V.
  • 17.13. Medtronic PLC
  • 17.14. NEScientific, Inc
  • 17.15. NIPRO CORPORATION
  • 17.16. RA Medical Systems, Inc.
  • 17.17. Rotarex, SA by Becton, Dickinson and Company
  • 17.18. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY FLUSH CASSETTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY FLUSH CASSETTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY FLUSH CASSETTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GUIDE WIRES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GUIDE WIRES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GUIDE WIRES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ADAPTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ADAPTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ROTATIONAL ADAPTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LARGE BURRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LARGE BURRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LARGE BURRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDIUM BURRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDIUM BURRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MEDIUM BURRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SMALL BURRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SMALL BURRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SMALL BURRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MILD CALCIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MILD CALCIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MILD CALCIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MODERATE CALCIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MODERATE CALCIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY MODERATE CALCIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NON CALCIFIED LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NON CALCIFIED LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NON CALCIFIED LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SEVERE CALCIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SEVERE CALCIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SEVERE CALCIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY CARDIAC SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NSTEMI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NSTEMI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY NSTEMI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STABLE ANGINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STABLE ANGINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STEMI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STEMI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY STEMI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY UNSTABLE ANGINA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY UNSTABLE ANGINA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 130. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 136. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 137. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. GCC PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 157. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 158. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. G7 PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 164. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 165. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. NATO PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY ATHERECTOMY BURRS, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY LESION TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA PERCUTANEOUS TRANSLUMINAL CORONARY ROTATIONAL ATHERECTOMY MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)